OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-PDZD2 antibodies
UltraMAB

Anti-PDZD2 GAT Antibody Polyclonal

Generated by Genomic Immunization

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA590362 Rabbit Polyclonal PDZK3 Antibody 100ug $325 In Stock
Add to Shopping Cart

spacer
IHC(1)
ELISA(1)

OriGene Data

ImmunogenDNA immunization. This antibody is specific for the Middle Region of the target protein.
Clone NamePolyclonal IsotypeIgG
Species ReactivityHuman Concentration0.70365 mg/ml
Guaranteed Application *ELISA, IHC Suggested DilutionsELISA: 1:100-1:2000; IHC: 1:250
Buffer20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0
Purification The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
Note This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT

Reference Data

Target NameHomo sapiens PDZ domain containing 2 (PDZD2)
Alternative NameAIPC; PAPIN; PDZK3; PIN1
Database LinkNP_835260
Entrez Gene 23037 Human
Function
Related PathwayDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

ELISA: PDZK3 Antibody
spacer
Immunohistochemical staining of human hippocampus shows strong nuclear positivity in glial cells.This validation was performed by Protein Atlas and the presentation of data is for informational purposes only.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title